Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience.

Chiru, E D; Grasic Kuhar, C; Oseledchyk, A; Schötzau, A; Gonzalez, M J; Kurzeder, C; Vetter, M

Chiru, E D; Grasic Kuhar, C; Oseledchyk, A; Schötzau, A; Gonzalez, M J; Kurzeder, C; Vetter, M.

Afiliación

Chiru ED; Medical Oncology, Basel University Hospital, Basel, Switzerland; Center of Oncology and Hematology, Cantonal Hospital Baselland, Liestal, Switzerland.
Grasic Kuhar C; Medical Oncology Department, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Oseledchyk A; Medical Oncology, Basel University Hospital, Basel, Switzerland.
Schötzau A; Department of Gynecologic Oncology, Basel University Hospital, Basel, Switzerland.
Gonzalez MJ; Adullam Hospital and care centers, Basel, Switzerland.
Kurzeder C; Breast Center, Basel University Hospital, Basel, Switzerland; Department of Gynecologic Oncology, Basel University Hospital, Basel, Switzerland.
Vetter M; Medical Oncology, Basel University Hospital, Basel, Switzerland; Center of Oncology and Hematology, Cantonal Hospital Baselland, Liestal, Switzerland; Breast Center, Basel University Hospital, Basel, Switzerland. Electronic address: marcus.vetter@ksbl.ch.

Transl Oncol ; 36: 101724, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37480708

Palabras clave

21-gene score; Chemotherapy; Early breast cancer; Endocrine therapy; Estrogen receptor positive; Older patients

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google